{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:13:10Z","timestamp":1760955190211},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11886-010-0085-x","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T08:23:48Z","timestamp":1267604628000},"page":"133-139","source":"Crossref","is-referenced-by-count":12,"title":["Anticoagulation for Mechanical Heart Valves in Patients with and without Atrial Fibrillation"],"prefix":"10.1007","volume":"12","author":[{"given":"Usman","family":"Baber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarina","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,4]]},"reference":[{"key":"85_CR1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0950268800003514","volume":"124","author":"JR Carapetis","year":"2000","unstructured":"Carapetis JR, Currie BJ, Mathews JD: Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population? Epidemiol Infect 2000, 124:239\u2013244.","journal-title":"Epidemiol Infect"},{"key":"85_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter SC, Rosendaal FR, Briet E: Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994, 89:635\u2013641.","journal-title":"Circulation"},{"key":"85_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1010-7940(88)80002-2","volume":"2","author":"EG Butchart","year":"1988","unstructured":"Butchart EG, Lewis PA, Kulatilake EN, Breckenridge IM: Anticoagulation variability between centres: implications for comparative prosthetic valve assessment. Eur J Cardiothorac Surg 1988, 2:72\u201381.","journal-title":"Eur J Cardiothorac Surg"},{"key":"85_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.bioeng.6.040803.140111","volume":"6","author":"AP Yoganathan","year":"2004","unstructured":"Yoganathan AP, He Z, Casey Jones S: Fluid mechanics of heart valves. Annu Rev Biomed Eng 2004, 6:331\u2013362.","journal-title":"Annu Rev Biomed Eng"},{"key":"85_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-8807(02)00128-X","volume":"12","author":"J Butany","year":"2003","unstructured":"Butany J, Ahluwalia MS, Munroe C, et al.: Mechanical heart valve prostheses: identification and evaluation. Cardiovasc Pathol 2003, 12:1\u201322.","journal-title":"Cardiovasc Pathol"},{"key":"85_CR6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2005.07.023","volume":"81","author":"A Kulik","year":"2006","unstructured":"Kulik A, Rubens FD, Wells PS, et al.: Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 2006, 81:770\u2013781.","journal-title":"Ann Thorac Surg"},{"key":"85_CR7","first-page":"e523","volume":"118","author":"RO Bonow","year":"2008","unstructured":"Bonow RO, Carabello BA, Chatterjee K, et al.: 2008 Focused update incorporated into the ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008, 118:e523\u2013e661.","journal-title":"Circulation"},{"key":"85_CR8","first-page":"230","volume":"28","author":"A Vahanian","year":"2007","unstructured":"Vahanian A, Baumgartner H, Bax J, et al.: Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007, 28:230\u2013268.","journal-title":"Eur Heart J"},{"key":"85_CR9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjcard.2003.09.054","volume":"93","author":"J Fanikos","year":"2004","unstructured":"Fanikos J, Tsilimingras K, Kucher N, et al.: Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004, 93:247\u2013250.","journal-title":"Am J Cardiol"},{"key":"85_CR10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.101.10.1083","volume":"101","author":"G Montalescot","year":"2000","unstructured":"Montalescot G, Polle V, Collet JP, et al.: Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000, 101:1083\u20131086.","journal-title":"Circulation"},{"key":"85_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","volume":"333","author":"SC Cannegieter","year":"1995","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR, et al.: Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995, 333:11\u201317.","journal-title":"N Engl J Med"},{"key":"85_CR12","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.94.9.2107","volume":"94","author":"J Acar","year":"1996","unstructured":"Acar J, Iung B, Boissel JP, et al.: AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996, 94:2107\u20132112.","journal-title":"Circulation"},{"key":"85_CR13","first-page":"III61","volume":"84","author":"EG Butchart","year":"1991","unstructured":"Butchart EG, Lewis PA, Bethel JA, Breckenridge IM: Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendations for the Medtronic Hall valve. Circulation 1991, 84:III61\u2013III69.","journal-title":"Circulation"},{"key":"85_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1378\/chest.127.1.53","volume":"127","author":"D Hering","year":"2005","unstructured":"Hering D, Piper C, Bergemann R, et al.: Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study. Chest 2005, 127:53\u201359.","journal-title":"Chest"},{"key":"85_CR15","doi-asserted-by":"crossref","first-page":"593S","DOI":"10.1378\/chest.08-0724","volume":"133","author":"DN Salem","year":"2008","unstructured":"Salem DN, O\u2019Gara PT, Madias C, Pauker SG: Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:593S\u2013629S.","journal-title":"Chest"},{"key":"85_CR16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mtc.2002.121162","volume":"123","author":"EG Butchart","year":"2002","unstructured":"Butchart EG, Payne N, Li HH, et al.: Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002, 123:715\u2013723.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl 6","key":"85_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s003920170019","volume":"90","author":"H Kortke","year":"2001","unstructured":"Kortke H, Minami K, Breymann T, et al.: [INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)]. Z Kardiol 2001, 90(Suppl 6):118\u2013124.","journal-title":"Z Kardiol"},{"key":"85_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.athoracsur.2006.08.036","volume":"83","author":"H Koertke","year":"2007","unstructured":"\u2022 Koertke H, Zittermann A, Wagner O, Koerfer R: Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg 2007, 83:24\u201329. This is a key trial demonstrating the impact of INR self-management on clinical outcomes among patients with mechanical prosthetic heart valves.","journal-title":"Ann Thorac Surg"},{"key":"85_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.281.2.145","volume":"281","author":"PT Sawicki","year":"1999","unstructured":"Sawicki PT: A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999, 281:145\u2013150.","journal-title":"JAMA"},{"key":"85_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(06)68139-7","volume":"367","author":"C Heneghan","year":"2006","unstructured":"Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al.: Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006, 367:404\u2013411.","journal-title":"Lancet"},{"key":"85_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-8703(87)90508-4","volume":"114","author":"LS Czer","year":"1987","unstructured":"Czer LS, Matloff JM, Chaux A, et al.: The St. Jude valve: analysis of thromboembolism, warfarin-related hemorrhage, and survival. Am Heart J 1987, 114:389\u2013397.","journal-title":"Am Heart J"},{"key":"85_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-5223(19)38486-7","volume":"91","author":"PA Ribeiro","year":"1986","unstructured":"Ribeiro PA, AlZaibag M, Idris M et al.: Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease. J Thorac Cardiovasc Surg 1986, 91:92\u201398.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"85_CR23","doi-asserted-by":"crossref","unstructured":"Little SH, Massel DR: Antiplatelet and anticoagulation for patients with prosthetic heart valves. Cochrane Database Syst Rev 2003, (4):CD003464.","DOI":"10.1002\/14651858.CD003464"},{"key":"85_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71\u201386.","journal-title":"BMJ"},{"key":"85_CR25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0165-6147(89)80010-0","volume":"10","author":"C Patrono","year":"1989","unstructured":"Patrono C: Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci 1989, 10:453\u2013458.","journal-title":"Trends Pharmacol Sci"},{"key":"85_CR26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archinte.158.15.1610","volume":"158","author":"MJ Wahl","year":"1998","unstructured":"Wahl MJ: Dental surgery in anticoagulated patients. Arch Intern Med 1998, 158:1610\u20131616.","journal-title":"Arch Intern Med"},{"key":"85_CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.89.5.527","volume":"89","author":"I Ferreira","year":"2003","unstructured":"Ferreira I, Dos L, Tornos P, et al.: Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol. Heart 2003, 89:527\u2013530.","journal-title":"Heart"},{"key":"85_CR28","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","volume":"110","author":"MJ Kovacs","year":"2004","unstructured":"Kovacs MJ, Kearon C, Rodger M, et al.: Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004, 110:1658\u20131663.","journal-title":"Circulation"},{"key":"85_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","volume":"114","author":"B Brenner","year":"2004","unstructured":"Brenner B: Haemostatic changes in pregnancy. Thromb Res 2004, 114:409\u2013414.","journal-title":"Thromb Res"},{"key":"85_CR30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V68.4.881.881","volume":"68","author":"PC Comp","year":"1986","unstructured":"Comp PC, Thurnau GR, Welsh J, Esmon CT: Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986, 68:881\u2013885.","journal-title":"Blood"},{"key":"85_CR31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","volume":"160","author":"WS Chan","year":"2000","unstructured":"Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000, 160:191\u2013196.","journal-title":"Arch Intern Med"},{"key":"85_CR32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2005.02.087","volume":"46","author":"U Elkayam","year":"2005","unstructured":"Elkayam U, Bitar F: Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol 2005, 46:403\u2013410.","journal-title":"J Am Coll Cardiol"},{"key":"85_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1646558","volume":"61","author":"JS Ginsberg","year":"1989","unstructured":"Ginsberg JS, Hirsh J, Turner DC, et al.: Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989, 61:197\u2013203.","journal-title":"Thromb Haemost"},{"key":"85_CR34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","volume":"68","author":"JG Hall","year":"1980","unstructured":"Hall JG, Pauli RM, Wilson KM: Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980, 68:122\u2013140.","journal-title":"Am J Med"},{"key":"85_CR35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1650255","volume":"75","author":"JD Douketis","year":"1996","unstructured":"Douketis JD, Ginsberg JS, Burrows RF, et al.: The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study. Thromb Haemost 1996, 75:254\u2013257.","journal-title":"Thromb Haemost"},{"key":"85_CR36","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","volume":"332","author":"TE Warkentin","year":"1995","unstructured":"Warkentin TE, Levine MN, Hirsh J, et al.: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995, 332:1330\u20131335.","journal-title":"N Engl J Med"},{"key":"85_CR37","first-page":"314","volume":"23","author":"J Harenberg","year":"1993","unstructured":"Harenberg J, Schneider D, Heilmann L, Wolf H: Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis 1993, 23:314\u2013320.","journal-title":"Haemostasis"},{"key":"85_CR38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","volume":"337","author":"JI Weitz","year":"1997","unstructured":"Weitz JI: Low-molecular-weight heparins. N Engl J Med 1997, 337:688\u2013698.","journal-title":"N Engl J Med"},{"key":"85_CR39","first-page":"844","volume":"9","author":"N Berndt","year":"2000","unstructured":"Berndt N, Khan I, Gallo R: A complication in anticoagulation using low-molecular weight heparin in a patient with a mechanical valve prosthesis. A case report. J Heart Valve Dis 2000, 9:844\u2013846.","journal-title":"J Heart Valve Dis"},{"key":"85_CR40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0003-4975(99)00874-7","volume":"69","author":"O Lev-Ran","year":"2000","unstructured":"Lev-Ran O, Kramer A, Gurevitch J, et al.: Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000, 69:264\u2013265; discussion 265\u2013266.","journal-title":"Ann Thorac Surg"},{"key":"85_CR41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983\u2013988.","journal-title":"Stroke"},{"key":"85_CR42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"\u2022\u2022 Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007, 146:857\u2013867. This is a comprehensive meta-analysis evaluating antithrombotic approaches in AF.","journal-title":"Ann Intern Med"},{"key":"85_CR43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/eurheartj\/ehm575","volume":"29","author":"AG Turpie","year":"2008","unstructured":"Turpie AG: New oral anticoagulants in atrial fibrillation. Eur Heart J 2008, 29:155\u2013165.","journal-title":"Eur Heart J"},{"key":"85_CR44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"\u2022\u2022 Connolly SJ, Ezekowitz MD, Yusuf S, et al.: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139\u20131151. This is a landmark trial evaluating a novel oral anticoagulant in AF.","journal-title":"N Engl J Med"},{"key":"85_CR45","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1538-7836.2007.02764.x","volume":"5","author":"MR Lassen","year":"2007","unstructured":"Lassen MR, Davidson BL, Gallus A, et al.: The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. J Thromb Haemost 2007, 5:2368\u20132375.","journal-title":"J Thromb Haemost"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-010-0085-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-010-0085-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-010-0085-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T20:26:02Z","timestamp":1590697562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-010-0085-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s11886-010-0085-x","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}